Literature DB >> 22692130

An efficient method for variable region assembly in the construction of scFv phage display libraries using independent strand amplification.

Pablo Sotelo1, Noberto Collazo, Roberto Zuñiga, Matías Gutiérrez-González, Diego Catalán, Carolina Hager Ribeiro, Juan Carlos Aguillón, María Carmen Molina.   

Abstract

Phage display library technology is a common method to produce human antibodies. In this technique, the immunoglobulin variable regions are displayed in a bacteriophage in a way that each filamentous virus displays the product of a single antibody gene on its surface. From the collection of different phages, it is possible to isolate the virus that recognizes specific targets. The most common form in which to display antibody variable regions in the phage is the single chain variable fragment format (scFv), which requires assembly of the heavy and light immunoglobulin variable regions in a single gene. In this work, we describe a simple and efficient method for the assembly of immunoglobulin heavy and light chain variable regions in a scFv format. This procedure involves a two-step reaction: (1) DNA amplification to produce the single strand form of the heavy or light chain gene required for the fusion; and (2) mixture of both single strand products followed by an assembly reaction to construct a complete scFv gene. Using this method, we produced 6-fold more scFv encoding DNA than the commonly used splicing by overlap extension PCR (SOE-PCR) approach. The scFv gene produced by this method also proved to be efficient in generating a diverse scFv phage display library. From this scFv library, we obtained phages that bound several non-related antigens, including recombinant proteins and rotavirus particles.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22692130      PMCID: PMC3499348          DOI: 10.4161/mabs.20653

Source DB:  PubMed          Journal:  MAbs        ISSN: 1942-0862            Impact factor:   5.857


  40 in total

Review 1.  Development trends for human monoclonal antibody therapeutics.

Authors:  Aaron L Nelson; Eugen Dhimolea; Janice M Reichert
Journal:  Nat Rev Drug Discov       Date:  2010-09-03       Impact factor: 84.694

Review 2.  Engineered antibody fragments and the rise of single domains.

Authors:  Philipp Holliger; Peter J Hudson
Journal:  Nat Biotechnol       Date:  2005-09       Impact factor: 54.908

Review 3.  The use of antibodies in the treatment of infectious diseases.

Authors:  C E Z Chan; A H Y Chan; B J Hanson; E E Ooi
Journal:  Singapore Med J       Date:  2009-07       Impact factor: 1.858

4.  Demonstration of specific antibodies against infliximab induced during treatment of a patient with ankylosing spondylitis.

Authors:  Canan Aybay; Sumru Ozel; Cemalettin Aybay
Journal:  Rheumatol Int       Date:  2005-12-09       Impact factor: 2.631

Review 5.  Bispecific antibodies for cancer immunotherapy: Current perspectives.

Authors:  Dafne Müller; Roland E Kontermann
Journal:  BioDrugs       Date:  2010-04-01       Impact factor: 5.807

Review 6.  Antibodies for HIV treatment and prevention: window of opportunity?

Authors:  M Huber; W C Olson; A Trkola
Journal:  Curr Top Microbiol Immunol       Date:  2008       Impact factor: 4.291

7.  Affinity maturation of a humanized rat antibody for anti-RAGE therapy: comprehensive mutagenesis reveals a high level of mutational plasticity both inside and outside the complementarity-determining regions.

Authors:  William J Finlay; Orla Cunningham; Matthew A Lambert; Alfredo Darmanin-Sheehan; Xuemei Liu; Brian J Fennell; Ciara M Mahon; Emma Cummins; Jason M Wade; Cliona M O'Sullivan; Xiang Yang Tan; Nicole Piche; Debra D Pittman; Janet Paulsen; Lioudmila Tchistiakova; Sreekumar Kodangattil; Davinder Gill; Simon E Hufton
Journal:  J Mol Biol       Date:  2009-03-13       Impact factor: 5.469

8.  Precise determination of the diversity of a combinatorial antibody library gives insight into the human immunoglobulin repertoire.

Authors:  Jacob Glanville; Wenwu Zhai; Jan Berka; Dilduz Telman; Gabriella Huerta; Gautam R Mehta; Irene Ni; Li Mei; Purnima D Sundar; Giles M R Day; David Cox; Arvind Rajpal; Jaume Pons
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-29       Impact factor: 11.205

Review 9.  Antibody-based proteomics: fast-tracking molecular diagnostics in oncology.

Authors:  Donal J Brennan; Darran P O'Connor; Elton Rexhepaj; Fredrik Ponten; William M Gallagher
Journal:  Nat Rev Cancer       Date:  2010-08-19       Impact factor: 60.716

10.  A compact phage display human scFv library for selection of antibodies to a wide variety of antigens.

Authors:  Potjamas Pansri; Nanthnit Jaruseranee; Kuntalee Rangnoi; Peter Kristensen; Montarop Yamabhai
Journal:  BMC Biotechnol       Date:  2009-01-29       Impact factor: 2.563

View more
  3 in total

Review 1.  Design and implementation of adoptive therapy with chimeric antigen receptor-modified T cells.

Authors:  Michael C Jensen; Stanley R Riddell
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

2.  Optimization of culture conditions for the expression of three different insoluble proteins in Escherichia coli.

Authors:  Matías Gutiérrez-González; Camila Farías; Samantha Tello; Diana Pérez-Etcheverry; Alfonso Romero; Roberto Zúñiga; Carolina H Ribeiro; Carmen Lorenzo-Ferreiro; María Carmen Molina
Journal:  Sci Rep       Date:  2019-11-14       Impact factor: 4.379

Review 3.  Naïve Human Antibody Libraries for Infectious Diseases.

Authors:  Soo Khim Chan; Anizah Rahumatullah; Jing Yi Lai; Theam Soon Lim
Journal:  Adv Exp Med Biol       Date:  2017       Impact factor: 2.622

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.